ArticleCJC open2020

Cost-Effectiveness of Earlier Transition to Angiotensin Receptor Neprilysin Inhibitor in Patients With Heart Failure and Reduced Ejection Fraction.

Andrew D M Grant et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.